Form 8-K - Current report:
SEC Accession No. 0001193125-25-137150
Filing Date
2025-06-06
Accepted
2025-06-06 16:48:34
Documents
12
Period of Report
2025-06-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d58104d8k.htm   iXBRL 8-K 41931
  Complete submission text file 0001193125-25-137150.txt   156554

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA svra-20250605.xsd EX-101.SCH 2865
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20250605_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20250605_pre.xml EX-101.PRE 11271
15 EXTRACTED XBRL INSTANCE DOCUMENT d58104d8k_htm.xml XML 3670
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 251031421
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)